NSAIDs pose significantly higher risks in older adults, including substantially increased chances of stomach bleeding, kidney problems, and cardiovascular events
Technical Specifications Compound: Glycyl-L-Histidyl-L-Lysine Copper Complex (GHK-Cu) Format: Lyophilized peptide Strength: 50 mg per vial Purity: 9899% (COA included) Appearance: Blue-hued lyophilized powder Category: Research reagent (non-clinical) Intended Use This product is intended exclusively for: Laboratory research In-vitro experimentation Biochemical and molecular assays Mechanistic pathway studies Preclinical, non-human model exploration Institutional or academic research programs Not intended for: Human or veterinary consumption Cosmetic or dermatological use Injection, ingestion, inhalation, or topical use Medical, therapeutic, or clinical applications This material is not approved by Health Canada, FDA, or any regulatory authority for clinical use
GHK-Cu was first identified in human plasma decades ago, and researchers quickly noticed something distinctive about it: circulating levels are highest in young adulthood and drop substantially with age
Copper peptides have proven to extend the life of the growth phase
Our formula contains the minerals manganese, zinc and copper, which contribute to the protection of cells from oxidative stress and act as precursors to the SOD variations